12 / 04 / 2023
Considering the importance of dendritic cells in fine-tuning T cell response, their manipulation represents an attractive approach to elicit or boost an anti-tumor immune response. To this end, we have developed and validated a mixed leukocyte reaction (MLR) assay to address DC function and evaluate their immune-modulatory properties.
11 / 13 / 2023
Check out – Our mustachioed icon as favorite image of November!
What better than the bold father of Immunology as an icon of our call for awareness for Movember!
10 / 18 / 2023
While mastering the key specifications of our macrophage-based models and their subtleties, our scientific and experimental expertise governs the relevance of our macrophage assays in evaluating the efficacy of immunotherapeutics either on the stimulatory M1 capacities or, especially, in relieving the suppressive functions of M2 macrophages.
10 / 11 / 2023
Check out – It’s our favorite image for Pink October this year!
Pink October: more than a month, more than a mission, but one of our commitments that we reaffirm every year.
09 / 21 / 2023
Conversing with Professor Antoine Italiano, a worldwide expert on early drug development, phase I oncology trials and immuno-oncology, upon the release of a recent article in Clinical Cancer Research.
09 / 18 / 2023
Our favorite image to raise awareness for childhood cancer!
We at Explicyte are fully committed to advancing cancer research and bring a bright future to all children!
07 / 19 / 2023
Check out – It’s our favorite image for this Sarcoma Awareness July!
Because we are committed to our missions to fight cancer, we at Explicyte are calling for awareness about sarcoma and bone cancer.
06 / 26 / 2023
Check out – It’s our favorite image of June!
T cells, macrophages, NKs, dendritic cells, mast cells..., the entire Explicyte team is proud to wear white and even show up in our preferred white cells warriors - fighting together to beat back cancer!
06 / 16 / 2023
ASCO Annual Meeting ended last week! Back in France, our CEO, Alban Bessede shares with us his observations and thoughts on this year’s edition 💡
06 / 08 / 2023
June is Cancer Immunotherapy Awareness Month
As experts in immuno-oncology, we at Explicyte are fully committed to making cancer immunotherapy a standard of care known to as many people as possible.